Cargando…

Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.

Various facts are now known about the relative lymphoma resistance of a group of tetraparental AKR reversible CBA/H-T6 chimaeras derived by early embryo aggregation. Firstly, their tumour resistance is not due to the lack of the lymphomaprone AKR cells. Secondly, results showing titres of MuLV-gs an...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, R. D., Tuffrey, M., Holliday, J., Hilgers, J. H., Souissi, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1976
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025139/
https://www.ncbi.nlm.nih.gov/pubmed/182191
_version_ 1782136704333774848
author Barnes, R. D.
Tuffrey, M.
Holliday, J.
Hilgers, J. H.
Souissi, T.
author_facet Barnes, R. D.
Tuffrey, M.
Holliday, J.
Hilgers, J. H.
Souissi, T.
author_sort Barnes, R. D.
collection PubMed
description Various facts are now known about the relative lymphoma resistance of a group of tetraparental AKR reversible CBA/H-T6 chimaeras derived by early embryo aggregation. Firstly, their tumour resistance is not due to the lack of the lymphomaprone AKR cells. Secondly, results showing titres of MuLV-gs antigen comparable with, and occasionally in excess of, those in the AKR suggest that the tumour resistance of the chimaeras is unlikely to be due to a lack of oncogenic leukaemia virus. However, in marked contrast to the AKR, antibody-viral antigen renal complexes in the chimaeras were minimal. Lack of viral antigens could not explain the relative lack of renal complexes. Absence of the corresponding anti-viral antibody is the most likely explanation and this has to be attributed to the CBA component of the tetraparental AKR reversible CBA/H-T6 chimaeras. We suggest that with tolerance to the leukaemia virus being maintained and in the absence of anti-viral antigenic complexes, tumour-specific sites can be recognized and thus tumours are eliminated. This hypothesis remains to be proven. IMAGES:
format Text
id pubmed-2025139
institution National Center for Biotechnology Information
language English
publishDate 1976
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20251392009-09-10 Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras. Barnes, R. D. Tuffrey, M. Holliday, J. Hilgers, J. H. Souissi, T. Br J Cancer Research Article Various facts are now known about the relative lymphoma resistance of a group of tetraparental AKR reversible CBA/H-T6 chimaeras derived by early embryo aggregation. Firstly, their tumour resistance is not due to the lack of the lymphomaprone AKR cells. Secondly, results showing titres of MuLV-gs antigen comparable with, and occasionally in excess of, those in the AKR suggest that the tumour resistance of the chimaeras is unlikely to be due to a lack of oncogenic leukaemia virus. However, in marked contrast to the AKR, antibody-viral antigen renal complexes in the chimaeras were minimal. Lack of viral antigens could not explain the relative lack of renal complexes. Absence of the corresponding anti-viral antibody is the most likely explanation and this has to be attributed to the CBA component of the tetraparental AKR reversible CBA/H-T6 chimaeras. We suggest that with tolerance to the leukaemia virus being maintained and in the absence of anti-viral antigenic complexes, tumour-specific sites can be recognized and thus tumours are eliminated. This hypothesis remains to be proven. IMAGES: Nature Publishing Group 1976-07 /pmc/articles/PMC2025139/ /pubmed/182191 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Barnes, R. D.
Tuffrey, M.
Holliday, J.
Hilgers, J. H.
Souissi, T.
Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title_full Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title_fullStr Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title_full_unstemmed Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title_short Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
title_sort murine leukaemia virus group-specific antigen in tumor-resistant tetraparental akr reversible cba/h-t6 chimaeras.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025139/
https://www.ncbi.nlm.nih.gov/pubmed/182191
work_keys_str_mv AT barnesrd murineleukaemiavirusgroupspecificantigenintumorresistanttetraparentalakrreversiblecbaht6chimaeras
AT tuffreym murineleukaemiavirusgroupspecificantigenintumorresistanttetraparentalakrreversiblecbaht6chimaeras
AT hollidayj murineleukaemiavirusgroupspecificantigenintumorresistanttetraparentalakrreversiblecbaht6chimaeras
AT hilgersjh murineleukaemiavirusgroupspecificantigenintumorresistanttetraparentalakrreversiblecbaht6chimaeras
AT souissit murineleukaemiavirusgroupspecificantigenintumorresistanttetraparentalakrreversiblecbaht6chimaeras